You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Medtronic
Colorcon
Baxter
McKinsey
Dow
Moodys

Last Updated: August 14, 2020

DrugPatentWatch Database Preview

INFUMORPH Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

When do Infumorph patents expire, and what generic alternatives are available?

Infumorph is a drug marketed by Hikma and is included in one NDA.

The generic ingredient in INFUMORPH is morphine sulfate. There are twenty-three drug master file entries for this compound. Forty suppliers are listed for this compound. Additional details are available on the morphine sulfate profile page.

US ANDA Litigation and Generic Entry Outlook for Infumorph

A generic version of INFUMORPH was approved as morphine sulfate by HOSPIRA on May 11th, 1988.

  Start Trial

Drug patent expirations by year for INFUMORPH
Drug Prices for INFUMORPH

See drug prices for INFUMORPH

Recent Clinical Trials for INFUMORPH

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Abdelrady S Ibrahim, MDPhase 2
Duke UniversityPhase 4
National Institutes of Health (NIH)Phase 4

See all INFUMORPH clinical trials

Pharmacology for INFUMORPH
Drug ClassOpioid Agonist
Mechanism of ActionFull Opioid Agonists

US Patents and Regulatory Information for INFUMORPH

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hikma INFUMORPH morphine sulfate INJECTABLE;INJECTION 018565-003 Jul 19, 1991 AP RX Yes Yes   Start Trial   Start Trial   Start Trial
Hikma INFUMORPH morphine sulfate INJECTABLE;INJECTION 018565-004 Jul 19, 1991 AP RX Yes Yes   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Moodys
Boehringer Ingelheim
McKesson
Dow
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.